Cargando…

Mutant PrP Suppresses Glutamatergic Neurotransmission in Cerebellar Granule Neurons by Impairing Membrane Delivery of VGCC α(2)δ-1 Subunit

How mutant prion protein (PrP) leads to neurological dysfunction in genetic prion diseases is unknown. Tg(PG14) mice synthesize a misfolded mutant PrP which is partially retained in the neuronal endoplasmic reticulum (ER). As these mice age, they develop ataxia and massive degeneration of cerebellar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senatore, Assunta, Colleoni, Simona, Verderio, Claudia, Restelli, Elena, Morini, Raffaella, Condliffe, Steven B., Bertani, Ilaria, Mantovani, Susanna, Canovi, Mara, Micotti, Edoardo, Forloni, Gianluigi, Dolphin, Annette C., Matteoli, Michela, Gobbi, Marco, Chiesa, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339322/ https://www.ncbi.nlm.nih.gov/pubmed/22542184 http://dx.doi.org/10.1016/j.neuron.2012.02.027

Ejemplares similares

Expression of Mutant or Cytosolic PrP in Transgenic Mice and Cells Is Not Associated with Endoplasmic Reticulum Stress or Proteasome Dysfunction
por: Quaglio, Elena, et al.
Publicado: (2011)

Targeted sensors for glutamatergic neurotransmission
por: Hao, Yuchen, et al.
Publicado: (2023)

Effects of Psychotherapy on Glutamatergic Neurotransmission
por: Wade-Bohleber, Laura, et al.
Publicado: (2023)

Glial activation in prion diseases is selectively triggered by neuronal PrP(Sc)
por: Lakkaraju, Asvin K. K., et al.
Publicado: (2022)

Synaptic Dysfunction in Prion Diseases: A Trafficking Problem?
por: Senatore, Assunta, et al.
Publicado: (2013)

Mutant prion proteins increase calcium permeability of AMPA receptors, exacerbating excitotoxicity
por: Ghirardini, Elsa, et al.
Publicado: (2020)

Correction: Mutant prion proteins increase calcium permeability of AMPA receptors, exacerbating excitotoxicity
por: Ghirardini, Elsa, et al.
Publicado: (2020)

Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicity
por: Chiesa, Roberto, et al.
Publicado: (2016)

Changes in glutamatergic neurotransmission within the migraine cycle
por: Cosentino, G, et al.
Publicado: (2013)

Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
por: Montanari, Martina, et al.
Publicado: (2022)

TMS-EEG signatures of glutamatergic neurotransmission in human cortex
por: Belardinelli, Paolo, et al.
Publicado: (2021)

Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea
por: Kaczmarski, Piotr, et al.
Publicado: (2023)

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior
por: Basu, Alo C., et al.
Publicado: (2008)

Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP
por: Sakudo, Akikazu, et al.
Publicado: (2015)

Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies
por: Winklehner, Michael, et al.
Publicado: (2022)

The inhibition of functional expression of calcium channels by prion protein demonstrates competition with α(2)δ for GPI-anchoring pathways
por: Alvarez-Laviada, Anita, et al.
Publicado: (2014)

Microglial Morphology and Dynamic Behavior Is Regulated by Ionotropic Glutamatergic and GABAergic Neurotransmission
por: Fontainhas, Aurora M., et al.
Publicado: (2011)

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
por: Kadriu, Bashkim, et al.
Publicado: (2018)

Ketamine attenuates the glutamatergic neurotransmission in the ventral posteromedial nucleus slices of rats
por: Fu, Bao, et al.
Publicado: (2017)

The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020)

The Structure of PrP(Sc) Prions
por: Wille, Holger, et al.
Publicado: (2018)

PrP Expression, PrP(Sc) Accumulation and Innervation of Splenic Compartments in Sheep Experimentally Infected with Scrapie
por: Sørby, Randi, et al.
Publicado: (2009)

Anti-Prion Drug mPPIg5 Inhibits PrP(C) Conversion to PrP(Sc)
por: McCarthy, James M., et al.
Publicado: (2013)

Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions
por: Miyazawa, Kohtaro, et al.
Publicado: (2015)

The native state of prion protein (PrP) directly inhibits formation of PrP-amyloid fibrils in vitro
por: Honda, Ryo P., et al.
Publicado: (2017)

Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice
por: Henzi, Anna, et al.
Publicado: (2020)

Predicting the consequences of selecting on PrP genotypes on PrP frequencies, performance and inbreeding in commercial meat sheep populations
por: Man, Wing-Young N, et al.
Publicado: (2007)

PK-sensitive PrP(Sc) Is Infectious and Shares Basic Structural Features with PK-resistant PrP(Sc)
por: Sajnani, Gustavo, et al.
Publicado: (2012)

Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission
por: Scoriels, L, et al.
Publicado: (2015)

Key role of the dopamine D(4) receptor in the modulation of corticostriatal glutamatergic neurotransmission
por: Bonaventura, Jordi, et al.
Publicado: (2017)

Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?
por: Khlghatyan, Jivan, et al.
Publicado: (2018)

Small Protease Sensitive Oligomers of PrP(Sc) in Distinct Human Prions Determine Conversion Rate of PrP(C)
por: Kim, Chae, et al.
Publicado: (2012)

Glimepiride Reduces the Expression of PrP(C), Prevents PrP(Sc) Formation and Protects against Prion Mediated Neurotoxicity
por: Bate, Clive, et al.
Publicado: (2009)

A Camelid Anti-PrP Antibody Abrogates PrP(Sc) Replication in Prion-Permissive Neuroblastoma Cell Lines
por: Jones, Daryl Rhys, et al.
Publicado: (2010)

Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibition
por: Taguchi, Yuzuru, et al.
Publicado: (2013)

PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions
por: Barron, Rona M., et al.
Publicado: (2016)

Recombinant PrP(Sc) shares structural features with brain-derived PrP(Sc): Insights from limited proteolysis
por: Sevillano, Alejandro M., et al.
Publicado: (2018)

Exploration of the Main Sites for the Transformation of Normal Prion Protein (PrP(C)) into Pathogenic Prion Protein (PrP(sc))
por: Liu, Xi-Lin, et al.
Publicado: (2017)

Na(+)/K(+)-ATPase Is Present in Scrapie-Associated Fibrils, Modulates PrP Misfolding In Vitro and Links PrP Function and Dysfunction
por: Graham, James F., et al.
Publicado: (2011)

Nanopore Analysis of Wild-Type and Mutant Prion Protein (PrP(C)): Single Molecule Discrimination and PrP(C) Kinetics
por: Jetha, Nahid N., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ki9rqi51etoeqdsgfkqkq2ejds